|
業務類別
|
Biotechnology |
|
業務概覽
|
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology. |
| 公司地址
| 701 Veterans Circle, Warminster, PA, USA, 18974 |
| 電話號碼
| +1 267 469-0914 |
| 傳真號碼
| +1 267 282-0411 |
| 公司網頁
| http://www.arbutusbio.com |
| 員工數量
| 44 |
| Mr. Tuan Nguyen |
Chief Financial Officer |
-- |
04/04/2025 |
| Ms. Lindsay Androski, C.F.A.,J.D.,M.B.A. |
Director, President and Chief Executive Officer |
-- |
25/02/2025 |
|
|
| Mr. Joseph Bishop |
Director |
25/02/2025 |
| Mr. Matthew Gline |
Director |
25/02/2025 |
| Dr. Roger Sawhney |
Director |
06/08/2025 |
| Mr. Robert A. Beardsley, PhD |
Director |
25/02/2025 |
| Ms. Lindsay Androski, C.F.A.,J.D.,M.B.A. |
Director, President and Chief Executive Officer |
25/02/2025 |
|
|
|
|
